The spectrum of thyroid dysfunction in an Australian hepatitis C population treated with combination Interferon-α2β and Ribavirin

by Batey Robert G, Jones Tracey L, Tran Huy A
Published 2005-10-01

Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C undergoing combination therapy: A nested case control study

by Reeves Glenn EM, Gibson Robert, Jones Tracey L, Tran Huy A
Published 2011-05-01

The natural history of interferon-α induced thyroiditis in chronic hepatitis c patients: a long term study

by Tran Huy A, Jones Tracey L, Ianna Elizabeth A, Reeves Glenn EM
Published 2011-01-01